Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Why do we celebrate the International Clinical Trials Day?

What happened 271 ago? In May 1747, at a time when scurvy was rampant among sailors, James Lind, a pioneer of naval hygiene, conducted what is now considered to be the very first clinical trial. Lind, a surgeon mate on board HMS Salisbury, recruited twelve men into a study that investigated which acidic substances could cure scurvy (spoiler alert: it was citrus fruits).

Clinical Trials DaySince then, May 20th is widely celebrated as the International Clinical Trials Day. It is an occasion to highlight the importance of clinical trials, raise awareness of participation opportunities and discuss the process of volunteering – and members of Paediatrics’ Oxford Vaccine Group have been on board with the celebrations. Alongside leaflets and stickers, Annabel Coxon and Rebecca Beckley brought in a set of Lego people, which helped to explain how herd immunity works. The Lego game has been a hit with children and adults alike!

To get involved in the clinical trials run by Paediatrics, visit our recruiting page.

 

 

 

 

 

 

 

 

 

Similar stories

How do muscles make us strong? Find out at IF Oxford Science & Ideas Festival

If you've ever wondered about the role of the muscle, come and meet us at IF Oxford - the Oxford science and ideas Festival on Saturday 8th & 15th October, when our researchers will be challenging members of the public to play our "Muscle Switch" game and exploring why strength differs between us.

It’s not just Covid: the triple threat that could overwhelm the NHS this winter - Andrew Pollard

A severe flu outbreak or new coronavirus variant could prove catastrophic for a health service already on its knees

Novel all-in-one vaccine developed to tackle future coronavirus threats

Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

Oral paratyphoid vaccine to begin human trials

The University of Oxford in collaboration with the University of Maryland School of Medicine (UMSoM) has begun recruiting for a Phase I/II trial of a new paratyphoid vaccine in human volunteers in Oxford.

Oxford scientist named Australian of the Year in the UK

The Oxford Vaccine Group’s Lead Statistician, Professor Merryn Voysey, received the prestigious Australian of the Year in the UK award at a gala dinner recently.